World Neurosurgery-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2120045, encodeId=92e421200456a, content=偏重的研究方向：脑卒中;神经内镜 经验分享：2月1投稿，5号外审，基本上2周变动一次盲审状态，2.5号25号，3月12号都在变更状态，不知道啥情况，希望有个好的结果吧！着急的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=849d4088301, createdName=13b745fdm39暂无昵称, createdTime=Thu Mar 16 21:21:49 CST 2023, time=2023-03-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1074684, encodeId=d6a510e4684ae, content=偏重的研究方向：脊柱 经验分享：请问这个期刊录用到网上见刊需要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad3b5501934, createdName=TCMGTC, createdTime=Sun Nov 28 07:32:51 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108306, encodeId=ad1a210830689, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：脊柱 经验分享：一审3个审稿人都给了好的评价，小修返后第二天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f5532042, createdName=ms9000002070546364, createdTime=Sat Dec 31 17:47:57 CST 2022, time=2022-12-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118739, encodeId=11452118e396e, content=2月20号投稿 2月25号under review 日期更新为3月5号under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65fd8321825, createdName=ms9000001818263895, createdTime=Fri Mar 10 23:39:12 CST 2023, time=2023-03-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104889, encodeId=370d2104889e6, content=偏重的研究方向：脊柱 经验分享：2022.11.07 投稿 2022.11.20 under review 2022.12.07 Required Reviews Completed 目前还在等待编辑决定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c608401801, createdName=ms9000001855664941, createdTime=Thu Dec 08 09:13:23 CST 2022, time=2022-12-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107436, encodeId=54fc210e436de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱 经验分享：还是比较快的，一审一个多月，大修后录取。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1JjG1vmt4PeQVwQy58nN7DUCHbhb9jnhSvcADOvbjdeIFVYrO8VeayjPYicG5DbRPtPTL1tiaVVicTLVUjXrF1WWg/132, createdBy=85db2404738, createdName=kk576, createdTime=Sun Dec 25 21:00:21 CST 2022, time=2022-12-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=925960, encodeId=ab1592596093, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审了将近四个月终于大修，凌晨提交傍晚就接收了，第一篇sci，很开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fc35388626, createdName=时坂紫, createdTime=Sun Feb 21 00:35:37 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588739, encodeId=20a8588e39de, content=我一篇临床文章被拒，被主编建议转投旗下杂志，被我拒绝，我改投一篇3分多的，结果接受了！dcn6460 2020-04-12 00:00:00 发表: 杂志由于目前收稿量大，对文章质量把关开始严格了。对于有兴趣但是达不到发表要求的文章会建议转投旗下的杂志。, beContent=dcn6460 2020-04-12 00:00:00 发表: 杂志由于目前收稿量大，对文章质量把关开始严格了。对于有兴趣但是达不到发表要求的文章会建议转投旗下的杂志。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203716, encodeId=4edb1203e162e, content=哪位同仁能分享一下投稿要求吗，guide for authors怎么也打不开了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325566391, createdName=ms3000000811234712, createdTime=Fri Mar 18 10:02:22 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966132, encodeId=c2eb966132ed, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：颅底肿瘤 经验分享：投稿很顺利，不到一个月接收。不过选择非OA会没有纸版文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42d93161, createdName=sunyanyien, createdTime=Sun May 16 23:46:33 CST 2021, time=2021-05-16, status=1, ipAttribution=)]

2023-03-16 13b745fdm39暂无昵称来自江苏省

偏重的研究方向：脑卒中;神经内镜
经验分享：2月1投稿，5号外审，基本上2周变动一次盲审状态，2.5号25号，3月12号都在变更状态，不知道啥情况，希望有个好的结果吧！着急的

40 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120045, encodeId=92e421200456a, content=偏重的研究方向：脑卒中;神经内镜 经验分享：2月1投稿，5号外审，基本上2周变动一次盲审状态，2.5号25号，3月12号都在变更状态，不知道啥情况，希望有个好的结果吧！着急的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=849d4088301, createdName=13b745fdm39暂无昵称, createdTime=Thu Mar 16 21:21:49 CST 2023, time=2023-03-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1074684, encodeId=d6a510e4684ae, content=偏重的研究方向：脊柱 经验分享：请问这个期刊录用到网上见刊需要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad3b5501934, createdName=TCMGTC, createdTime=Sun Nov 28 07:32:51 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108306, encodeId=ad1a210830689, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：脊柱 经验分享：一审3个审稿人都给了好的评价，小修返后第二天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f5532042, createdName=ms9000002070546364, createdTime=Sat Dec 31 17:47:57 CST 2022, time=2022-12-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118739, encodeId=11452118e396e, content=2月20号投稿 2月25号under review 日期更新为3月5号under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65fd8321825, createdName=ms9000001818263895, createdTime=Fri Mar 10 23:39:12 CST 2023, time=2023-03-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104889, encodeId=370d2104889e6, content=偏重的研究方向：脊柱 经验分享：2022.11.07 投稿 2022.11.20 under review 2022.12.07 Required Reviews Completed 目前还在等待编辑决定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c608401801, createdName=ms9000001855664941, createdTime=Thu Dec 08 09:13:23 CST 2022, time=2022-12-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107436, encodeId=54fc210e436de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱 经验分享：还是比较快的，一审一个多月，大修后录取。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1JjG1vmt4PeQVwQy58nN7DUCHbhb9jnhSvcADOvbjdeIFVYrO8VeayjPYicG5DbRPtPTL1tiaVVicTLVUjXrF1WWg/132, createdBy=85db2404738, createdName=kk576, createdTime=Sun Dec 25 21:00:21 CST 2022, time=2022-12-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=925960, encodeId=ab1592596093, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审了将近四个月终于大修，凌晨提交傍晚就接收了，第一篇sci，很开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fc35388626, createdName=时坂紫, createdTime=Sun Feb 21 00:35:37 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588739, encodeId=20a8588e39de, content=我一篇临床文章被拒，被主编建议转投旗下杂志，被我拒绝，我改投一篇3分多的，结果接受了！dcn6460 2020-04-12 00:00:00 发表: 杂志由于目前收稿量大，对文章质量把关开始严格了。对于有兴趣但是达不到发表要求的文章会建议转投旗下的杂志。, beContent=dcn6460 2020-04-12 00:00:00 发表: 杂志由于目前收稿量大，对文章质量把关开始严格了。对于有兴趣但是达不到发表要求的文章会建议转投旗下的杂志。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203716, encodeId=4edb1203e162e, content=哪位同仁能分享一下投稿要求吗，guide for authors怎么也打不开了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325566391, createdName=ms3000000811234712, createdTime=Fri Mar 18 10:02:22 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966132, encodeId=c2eb966132ed, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：颅底肿瘤 经验分享：投稿很顺利，不到一个月接收。不过选择非OA会没有纸版文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42d93161, createdName=sunyanyien, createdTime=Sun May 16 23:46:33 CST 2021, time=2021-05-16, status=1, ipAttribution=)]

2021-11-28 TCMGTC

偏重的研究方向：脊柱
经验分享：请问这个期刊录用到网上见刊需要多久呢

70 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120045, encodeId=92e421200456a, content=偏重的研究方向：脑卒中;神经内镜 经验分享：2月1投稿，5号外审，基本上2周变动一次盲审状态，2.5号25号，3月12号都在变更状态，不知道啥情况，希望有个好的结果吧！着急的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=849d4088301, createdName=13b745fdm39暂无昵称, createdTime=Thu Mar 16 21:21:49 CST 2023, time=2023-03-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1074684, encodeId=d6a510e4684ae, content=偏重的研究方向：脊柱 经验分享：请问这个期刊录用到网上见刊需要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad3b5501934, createdName=TCMGTC, createdTime=Sun Nov 28 07:32:51 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108306, encodeId=ad1a210830689, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：脊柱 经验分享：一审3个审稿人都给了好的评价，小修返后第二天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f5532042, createdName=ms9000002070546364, createdTime=Sat Dec 31 17:47:57 CST 2022, time=2022-12-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118739, encodeId=11452118e396e, content=2月20号投稿 2月25号under review 日期更新为3月5号under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65fd8321825, createdName=ms9000001818263895, createdTime=Fri Mar 10 23:39:12 CST 2023, time=2023-03-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104889, encodeId=370d2104889e6, content=偏重的研究方向：脊柱 经验分享：2022.11.07 投稿 2022.11.20 under review 2022.12.07 Required Reviews Completed 目前还在等待编辑决定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c608401801, createdName=ms9000001855664941, createdTime=Thu Dec 08 09:13:23 CST 2022, time=2022-12-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107436, encodeId=54fc210e436de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱 经验分享：还是比较快的，一审一个多月，大修后录取。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1JjG1vmt4PeQVwQy58nN7DUCHbhb9jnhSvcADOvbjdeIFVYrO8VeayjPYicG5DbRPtPTL1tiaVVicTLVUjXrF1WWg/132, createdBy=85db2404738, createdName=kk576, createdTime=Sun Dec 25 21:00:21 CST 2022, time=2022-12-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=925960, encodeId=ab1592596093, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审了将近四个月终于大修，凌晨提交傍晚就接收了，第一篇sci，很开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fc35388626, createdName=时坂紫, createdTime=Sun Feb 21 00:35:37 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588739, encodeId=20a8588e39de, content=我一篇临床文章被拒，被主编建议转投旗下杂志，被我拒绝，我改投一篇3分多的，结果接受了！dcn6460 2020-04-12 00:00:00 发表: 杂志由于目前收稿量大，对文章质量把关开始严格了。对于有兴趣但是达不到发表要求的文章会建议转投旗下的杂志。, beContent=dcn6460 2020-04-12 00:00:00 发表: 杂志由于目前收稿量大，对文章质量把关开始严格了。对于有兴趣但是达不到发表要求的文章会建议转投旗下的杂志。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203716, encodeId=4edb1203e162e, content=哪位同仁能分享一下投稿要求吗，guide for authors怎么也打不开了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325566391, createdName=ms3000000811234712, createdTime=Fri Mar 18 10:02:22 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966132, encodeId=c2eb966132ed, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：颅底肿瘤 经验分享：投稿很顺利，不到一个月接收。不过选择非OA会没有纸版文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42d93161, createdName=sunyanyien, createdTime=Sun May 16 23:46:33 CST 2021, time=2021-05-16, status=1, ipAttribution=)]

2022-12-31 ms9000002070546364 来自重庆

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：脊柱
经验分享：一审3个审稿人都给了好的评价，小修返后第二天接收。

38 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120045, encodeId=92e421200456a, content=偏重的研究方向：脑卒中;神经内镜 经验分享：2月1投稿，5号外审，基本上2周变动一次盲审状态，2.5号25号，3月12号都在变更状态，不知道啥情况，希望有个好的结果吧！着急的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=849d4088301, createdName=13b745fdm39暂无昵称, createdTime=Thu Mar 16 21:21:49 CST 2023, time=2023-03-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1074684, encodeId=d6a510e4684ae, content=偏重的研究方向：脊柱 经验分享：请问这个期刊录用到网上见刊需要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad3b5501934, createdName=TCMGTC, createdTime=Sun Nov 28 07:32:51 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108306, encodeId=ad1a210830689, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：脊柱 经验分享：一审3个审稿人都给了好的评价，小修返后第二天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f5532042, createdName=ms9000002070546364, createdTime=Sat Dec 31 17:47:57 CST 2022, time=2022-12-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118739, encodeId=11452118e396e, content=2月20号投稿 2月25号under review 日期更新为3月5号under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65fd8321825, createdName=ms9000001818263895, createdTime=Fri Mar 10 23:39:12 CST 2023, time=2023-03-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104889, encodeId=370d2104889e6, content=偏重的研究方向：脊柱 经验分享：2022.11.07 投稿 2022.11.20 under review 2022.12.07 Required Reviews Completed 目前还在等待编辑决定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c608401801, createdName=ms9000001855664941, createdTime=Thu Dec 08 09:13:23 CST 2022, time=2022-12-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107436, encodeId=54fc210e436de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱 经验分享：还是比较快的，一审一个多月，大修后录取。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1JjG1vmt4PeQVwQy58nN7DUCHbhb9jnhSvcADOvbjdeIFVYrO8VeayjPYicG5DbRPtPTL1tiaVVicTLVUjXrF1WWg/132, createdBy=85db2404738, createdName=kk576, createdTime=Sun Dec 25 21:00:21 CST 2022, time=2022-12-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=925960, encodeId=ab1592596093, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审了将近四个月终于大修，凌晨提交傍晚就接收了，第一篇sci，很开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fc35388626, createdName=时坂紫, createdTime=Sun Feb 21 00:35:37 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588739, encodeId=20a8588e39de, content=我一篇临床文章被拒，被主编建议转投旗下杂志，被我拒绝，我改投一篇3分多的，结果接受了！dcn6460 2020-04-12 00:00:00 发表: 杂志由于目前收稿量大，对文章质量把关开始严格了。对于有兴趣但是达不到发表要求的文章会建议转投旗下的杂志。, beContent=dcn6460 2020-04-12 00:00:00 发表: 杂志由于目前收稿量大，对文章质量把关开始严格了。对于有兴趣但是达不到发表要求的文章会建议转投旗下的杂志。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203716, encodeId=4edb1203e162e, content=哪位同仁能分享一下投稿要求吗，guide for authors怎么也打不开了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325566391, createdName=ms3000000811234712, createdTime=Fri Mar 18 10:02:22 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966132, encodeId=c2eb966132ed, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：颅底肿瘤 经验分享：投稿很顺利，不到一个月接收。不过选择非OA会没有纸版文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42d93161, createdName=sunyanyien, createdTime=Sun May 16 23:46:33 CST 2021, time=2021-05-16, status=1, ipAttribution=)]

2023-03-10 ms9000001818263895 来自辽宁省

2月20号投稿
2月25号under review
日期更新为3月5号under review

35 0

[GetPortalCommentsPageByObjectIdResponse(id=2120045, encodeId=92e421200456a, content=偏重的研究方向：脑卒中;神经内镜 经验分享：2月1投稿，5号外审，基本上2周变动一次盲审状态，2.5号25号，3月12号都在变更状态，不知道啥情况，希望有个好的结果吧！着急的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=849d4088301, createdName=13b745fdm39暂无昵称, createdTime=Thu Mar 16 21:21:49 CST 2023, time=2023-03-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1074684, encodeId=d6a510e4684ae, content=偏重的研究方向：脊柱 经验分享：请问这个期刊录用到网上见刊需要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad3b5501934, createdName=TCMGTC, createdTime=Sun Nov 28 07:32:51 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108306, encodeId=ad1a210830689, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：脊柱 经验分享：一审3个审稿人都给了好的评价，小修返后第二天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f5532042, createdName=ms9000002070546364, createdTime=Sat Dec 31 17:47:57 CST 2022, time=2022-12-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118739, encodeId=11452118e396e, content=2月20号投稿 2月25号under review 日期更新为3月5号under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65fd8321825, createdName=ms9000001818263895, createdTime=Fri Mar 10 23:39:12 CST 2023, time=2023-03-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104889, encodeId=370d2104889e6, content=偏重的研究方向：脊柱 经验分享：2022.11.07 投稿 2022.11.20 under review 2022.12.07 Required Reviews Completed 目前还在等待编辑决定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c608401801, createdName=ms9000001855664941, createdTime=Thu Dec 08 09:13:23 CST 2022, time=2022-12-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107436, encodeId=54fc210e436de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱 经验分享：还是比较快的，一审一个多月，大修后录取。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1JjG1vmt4PeQVwQy58nN7DUCHbhb9jnhSvcADOvbjdeIFVYrO8VeayjPYicG5DbRPtPTL1tiaVVicTLVUjXrF1WWg/132, createdBy=85db2404738, createdName=kk576, createdTime=Sun Dec 25 21:00:21 CST 2022, time=2022-12-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=925960, encodeId=ab1592596093, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审了将近四个月终于大修，凌晨提交傍晚就接收了，第一篇sci，很开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fc35388626, createdName=时坂紫, createdTime=Sun Feb 21 00:35:37 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588739, encodeId=20a8588e39de, content=我一篇临床文章被拒，被主编建议转投旗下杂志，被我拒绝，我改投一篇3分多的，结果接受了！dcn6460 2020-04-12 00:00:00 发表: 杂志由于目前收稿量大，对文章质量把关开始严格了。对于有兴趣但是达不到发表要求的文章会建议转投旗下的杂志。, beContent=dcn6460 2020-04-12 00:00:00 发表: 杂志由于目前收稿量大，对文章质量把关开始严格了。对于有兴趣但是达不到发表要求的文章会建议转投旗下的杂志。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203716, encodeId=4edb1203e162e, content=哪位同仁能分享一下投稿要求吗，guide for authors怎么也打不开了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325566391, createdName=ms3000000811234712, createdTime=Fri Mar 18 10:02:22 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966132, encodeId=c2eb966132ed, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：颅底肿瘤 经验分享：投稿很顺利，不到一个月接收。不过选择非OA会没有纸版文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42d93161, createdName=sunyanyien, createdTime=Sun May 16 23:46:33 CST 2021, time=2021-05-16, status=1, ipAttribution=)]

2022-12-08 ms9000001855664941 来自广东省

偏重的研究方向：脊柱
经验分享：2022.11.07 投稿
2022.11.20 under review
2022.12.07 Required Reviews Completed
目前还在等待编辑决定

368 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120045, encodeId=92e421200456a, content=偏重的研究方向：脑卒中;神经内镜 经验分享：2月1投稿，5号外审，基本上2周变动一次盲审状态，2.5号25号，3月12号都在变更状态，不知道啥情况，希望有个好的结果吧！着急的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=849d4088301, createdName=13b745fdm39暂无昵称, createdTime=Thu Mar 16 21:21:49 CST 2023, time=2023-03-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1074684, encodeId=d6a510e4684ae, content=偏重的研究方向：脊柱 经验分享：请问这个期刊录用到网上见刊需要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad3b5501934, createdName=TCMGTC, createdTime=Sun Nov 28 07:32:51 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108306, encodeId=ad1a210830689, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：脊柱 经验分享：一审3个审稿人都给了好的评价，小修返后第二天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f5532042, createdName=ms9000002070546364, createdTime=Sat Dec 31 17:47:57 CST 2022, time=2022-12-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118739, encodeId=11452118e396e, content=2月20号投稿 2月25号under review 日期更新为3月5号under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65fd8321825, createdName=ms9000001818263895, createdTime=Fri Mar 10 23:39:12 CST 2023, time=2023-03-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104889, encodeId=370d2104889e6, content=偏重的研究方向：脊柱 经验分享：2022.11.07 投稿 2022.11.20 under review 2022.12.07 Required Reviews Completed 目前还在等待编辑决定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c608401801, createdName=ms9000001855664941, createdTime=Thu Dec 08 09:13:23 CST 2022, time=2022-12-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107436, encodeId=54fc210e436de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱 经验分享：还是比较快的，一审一个多月，大修后录取。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1JjG1vmt4PeQVwQy58nN7DUCHbhb9jnhSvcADOvbjdeIFVYrO8VeayjPYicG5DbRPtPTL1tiaVVicTLVUjXrF1WWg/132, createdBy=85db2404738, createdName=kk576, createdTime=Sun Dec 25 21:00:21 CST 2022, time=2022-12-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=925960, encodeId=ab1592596093, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审了将近四个月终于大修，凌晨提交傍晚就接收了，第一篇sci，很开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fc35388626, createdName=时坂紫, createdTime=Sun Feb 21 00:35:37 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588739, encodeId=20a8588e39de, content=我一篇临床文章被拒，被主编建议转投旗下杂志，被我拒绝，我改投一篇3分多的，结果接受了！dcn6460 2020-04-12 00:00:00 发表: 杂志由于目前收稿量大，对文章质量把关开始严格了。对于有兴趣但是达不到发表要求的文章会建议转投旗下的杂志。, beContent=dcn6460 2020-04-12 00:00:00 发表: 杂志由于目前收稿量大，对文章质量把关开始严格了。对于有兴趣但是达不到发表要求的文章会建议转投旗下的杂志。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203716, encodeId=4edb1203e162e, content=哪位同仁能分享一下投稿要求吗，guide for authors怎么也打不开了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325566391, createdName=ms3000000811234712, createdTime=Fri Mar 18 10:02:22 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966132, encodeId=c2eb966132ed, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：颅底肿瘤 经验分享：投稿很顺利，不到一个月接收。不过选择非OA会没有纸版文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42d93161, createdName=sunyanyien, createdTime=Sun May 16 23:46:33 CST 2021, time=2021-05-16, status=1, ipAttribution=)]

2022-12-25 kk576 来自安徽省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：脊柱
经验分享：还是比较快的，一审一个多月，大修后录取。

65 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120045, encodeId=92e421200456a, content=偏重的研究方向：脑卒中;神经内镜 经验分享：2月1投稿，5号外审，基本上2周变动一次盲审状态，2.5号25号，3月12号都在变更状态，不知道啥情况，希望有个好的结果吧！着急的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=849d4088301, createdName=13b745fdm39暂无昵称, createdTime=Thu Mar 16 21:21:49 CST 2023, time=2023-03-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1074684, encodeId=d6a510e4684ae, content=偏重的研究方向：脊柱 经验分享：请问这个期刊录用到网上见刊需要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad3b5501934, createdName=TCMGTC, createdTime=Sun Nov 28 07:32:51 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108306, encodeId=ad1a210830689, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：脊柱 经验分享：一审3个审稿人都给了好的评价，小修返后第二天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f5532042, createdName=ms9000002070546364, createdTime=Sat Dec 31 17:47:57 CST 2022, time=2022-12-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118739, encodeId=11452118e396e, content=2月20号投稿 2月25号under review 日期更新为3月5号under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65fd8321825, createdName=ms9000001818263895, createdTime=Fri Mar 10 23:39:12 CST 2023, time=2023-03-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104889, encodeId=370d2104889e6, content=偏重的研究方向：脊柱 经验分享：2022.11.07 投稿 2022.11.20 under review 2022.12.07 Required Reviews Completed 目前还在等待编辑决定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c608401801, createdName=ms9000001855664941, createdTime=Thu Dec 08 09:13:23 CST 2022, time=2022-12-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107436, encodeId=54fc210e436de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱 经验分享：还是比较快的，一审一个多月，大修后录取。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1JjG1vmt4PeQVwQy58nN7DUCHbhb9jnhSvcADOvbjdeIFVYrO8VeayjPYicG5DbRPtPTL1tiaVVicTLVUjXrF1WWg/132, createdBy=85db2404738, createdName=kk576, createdTime=Sun Dec 25 21:00:21 CST 2022, time=2022-12-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=925960, encodeId=ab1592596093, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审了将近四个月终于大修，凌晨提交傍晚就接收了，第一篇sci，很开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fc35388626, createdName=时坂紫, createdTime=Sun Feb 21 00:35:37 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588739, encodeId=20a8588e39de, content=我一篇临床文章被拒，被主编建议转投旗下杂志，被我拒绝，我改投一篇3分多的，结果接受了！dcn6460 2020-04-12 00:00:00 发表: 杂志由于目前收稿量大，对文章质量把关开始严格了。对于有兴趣但是达不到发表要求的文章会建议转投旗下的杂志。, beContent=dcn6460 2020-04-12 00:00:00 发表: 杂志由于目前收稿量大，对文章质量把关开始严格了。对于有兴趣但是达不到发表要求的文章会建议转投旗下的杂志。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203716, encodeId=4edb1203e162e, content=哪位同仁能分享一下投稿要求吗，guide for authors怎么也打不开了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325566391, createdName=ms3000000811234712, createdTime=Fri Mar 18 10:02:22 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966132, encodeId=c2eb966132ed, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：颅底肿瘤 经验分享：投稿很顺利，不到一个月接收。不过选择非OA会没有纸版文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42d93161, createdName=sunyanyien, createdTime=Sun May 16 23:46:33 CST 2021, time=2021-05-16, status=1, ipAttribution=)]

2021-02-21 时坂紫

审稿速度:6.0 | 投稿命中率:25.0
经验分享：审了将近四个月终于大修，凌晨提交傍晚就接收了，第一篇sci，很开心

105 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120045, encodeId=92e421200456a, content=偏重的研究方向：脑卒中;神经内镜 经验分享：2月1投稿，5号外审，基本上2周变动一次盲审状态，2.5号25号，3月12号都在变更状态，不知道啥情况，希望有个好的结果吧！着急的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=849d4088301, createdName=13b745fdm39暂无昵称, createdTime=Thu Mar 16 21:21:49 CST 2023, time=2023-03-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1074684, encodeId=d6a510e4684ae, content=偏重的研究方向：脊柱 经验分享：请问这个期刊录用到网上见刊需要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad3b5501934, createdName=TCMGTC, createdTime=Sun Nov 28 07:32:51 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108306, encodeId=ad1a210830689, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：脊柱 经验分享：一审3个审稿人都给了好的评价，小修返后第二天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f5532042, createdName=ms9000002070546364, createdTime=Sat Dec 31 17:47:57 CST 2022, time=2022-12-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118739, encodeId=11452118e396e, content=2月20号投稿 2月25号under review 日期更新为3月5号under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65fd8321825, createdName=ms9000001818263895, createdTime=Fri Mar 10 23:39:12 CST 2023, time=2023-03-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104889, encodeId=370d2104889e6, content=偏重的研究方向：脊柱 经验分享：2022.11.07 投稿 2022.11.20 under review 2022.12.07 Required Reviews Completed 目前还在等待编辑决定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c608401801, createdName=ms9000001855664941, createdTime=Thu Dec 08 09:13:23 CST 2022, time=2022-12-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107436, encodeId=54fc210e436de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱 经验分享：还是比较快的，一审一个多月，大修后录取。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1JjG1vmt4PeQVwQy58nN7DUCHbhb9jnhSvcADOvbjdeIFVYrO8VeayjPYicG5DbRPtPTL1tiaVVicTLVUjXrF1WWg/132, createdBy=85db2404738, createdName=kk576, createdTime=Sun Dec 25 21:00:21 CST 2022, time=2022-12-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=925960, encodeId=ab1592596093, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审了将近四个月终于大修，凌晨提交傍晚就接收了，第一篇sci，很开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fc35388626, createdName=时坂紫, createdTime=Sun Feb 21 00:35:37 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588739, encodeId=20a8588e39de, content=我一篇临床文章被拒，被主编建议转投旗下杂志，被我拒绝，我改投一篇3分多的，结果接受了！dcn6460 2020-04-12 00:00:00 发表: 杂志由于目前收稿量大，对文章质量把关开始严格了。对于有兴趣但是达不到发表要求的文章会建议转投旗下的杂志。, beContent=dcn6460 2020-04-12 00:00:00 发表: 杂志由于目前收稿量大，对文章质量把关开始严格了。对于有兴趣但是达不到发表要求的文章会建议转投旗下的杂志。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203716, encodeId=4edb1203e162e, content=哪位同仁能分享一下投稿要求吗，guide for authors怎么也打不开了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325566391, createdName=ms3000000811234712, createdTime=Fri Mar 18 10:02:22 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966132, encodeId=c2eb966132ed, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：颅底肿瘤 经验分享：投稿很顺利，不到一个月接收。不过选择非OA会没有纸版文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42d93161, createdName=sunyanyien, createdTime=Sun May 16 23:46:33 CST 2021, time=2021-05-16, status=1, ipAttribution=)]

2020-04-13 weilinjie

我一篇临床文章被拒，被主编建议转投旗下杂志，被我拒绝，我改投一篇3分多的，结果接受了！dcn6460 2020-04-12 00:00:00 发表:
杂志由于目前收稿量大，对文章质量把关开始严格了。对于有兴趣但是达不到发表要求的文章会建议转投旗下的杂志。

dcn6460 2020-04-12 00:00:00 发表: 杂志由于目前收稿量大，对文章质量把关开始严格了。对于有兴趣但是达不到发表要求的文章会建议转投旗下的杂志。

122 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120045, encodeId=92e421200456a, content=偏重的研究方向：脑卒中;神经内镜 经验分享：2月1投稿，5号外审，基本上2周变动一次盲审状态，2.5号25号，3月12号都在变更状态，不知道啥情况，希望有个好的结果吧！着急的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=849d4088301, createdName=13b745fdm39暂无昵称, createdTime=Thu Mar 16 21:21:49 CST 2023, time=2023-03-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1074684, encodeId=d6a510e4684ae, content=偏重的研究方向：脊柱 经验分享：请问这个期刊录用到网上见刊需要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad3b5501934, createdName=TCMGTC, createdTime=Sun Nov 28 07:32:51 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108306, encodeId=ad1a210830689, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：脊柱 经验分享：一审3个审稿人都给了好的评价，小修返后第二天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f5532042, createdName=ms9000002070546364, createdTime=Sat Dec 31 17:47:57 CST 2022, time=2022-12-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118739, encodeId=11452118e396e, content=2月20号投稿 2月25号under review 日期更新为3月5号under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65fd8321825, createdName=ms9000001818263895, createdTime=Fri Mar 10 23:39:12 CST 2023, time=2023-03-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104889, encodeId=370d2104889e6, content=偏重的研究方向：脊柱 经验分享：2022.11.07 投稿 2022.11.20 under review 2022.12.07 Required Reviews Completed 目前还在等待编辑决定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c608401801, createdName=ms9000001855664941, createdTime=Thu Dec 08 09:13:23 CST 2022, time=2022-12-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107436, encodeId=54fc210e436de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱 经验分享：还是比较快的，一审一个多月，大修后录取。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1JjG1vmt4PeQVwQy58nN7DUCHbhb9jnhSvcADOvbjdeIFVYrO8VeayjPYicG5DbRPtPTL1tiaVVicTLVUjXrF1WWg/132, createdBy=85db2404738, createdName=kk576, createdTime=Sun Dec 25 21:00:21 CST 2022, time=2022-12-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=925960, encodeId=ab1592596093, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审了将近四个月终于大修，凌晨提交傍晚就接收了，第一篇sci，很开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fc35388626, createdName=时坂紫, createdTime=Sun Feb 21 00:35:37 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588739, encodeId=20a8588e39de, content=我一篇临床文章被拒，被主编建议转投旗下杂志，被我拒绝，我改投一篇3分多的，结果接受了！dcn6460 2020-04-12 00:00:00 发表: 杂志由于目前收稿量大，对文章质量把关开始严格了。对于有兴趣但是达不到发表要求的文章会建议转投旗下的杂志。, beContent=dcn6460 2020-04-12 00:00:00 发表: 杂志由于目前收稿量大，对文章质量把关开始严格了。对于有兴趣但是达不到发表要求的文章会建议转投旗下的杂志。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203716, encodeId=4edb1203e162e, content=哪位同仁能分享一下投稿要求吗，guide for authors怎么也打不开了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325566391, createdName=ms3000000811234712, createdTime=Fri Mar 18 10:02:22 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966132, encodeId=c2eb966132ed, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：颅底肿瘤 经验分享：投稿很顺利，不到一个月接收。不过选择非OA会没有纸版文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42d93161, createdName=sunyanyien, createdTime=Sun May 16 23:46:33 CST 2021, time=2021-05-16, status=1, ipAttribution=)]

2022-03-18 ms3000000811234712

哪位同仁能分享一下投稿要求吗，guide for authors怎么也打不开了

64 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120045, encodeId=92e421200456a, content=偏重的研究方向：脑卒中;神经内镜 经验分享：2月1投稿，5号外审，基本上2周变动一次盲审状态，2.5号25号，3月12号都在变更状态，不知道啥情况，希望有个好的结果吧！着急的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=849d4088301, createdName=13b745fdm39暂无昵称, createdTime=Thu Mar 16 21:21:49 CST 2023, time=2023-03-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1074684, encodeId=d6a510e4684ae, content=偏重的研究方向：脊柱 经验分享：请问这个期刊录用到网上见刊需要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad3b5501934, createdName=TCMGTC, createdTime=Sun Nov 28 07:32:51 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108306, encodeId=ad1a210830689, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：脊柱 经验分享：一审3个审稿人都给了好的评价，小修返后第二天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f5532042, createdName=ms9000002070546364, createdTime=Sat Dec 31 17:47:57 CST 2022, time=2022-12-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118739, encodeId=11452118e396e, content=2月20号投稿 2月25号under review 日期更新为3月5号under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65fd8321825, createdName=ms9000001818263895, createdTime=Fri Mar 10 23:39:12 CST 2023, time=2023-03-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104889, encodeId=370d2104889e6, content=偏重的研究方向：脊柱 经验分享：2022.11.07 投稿 2022.11.20 under review 2022.12.07 Required Reviews Completed 目前还在等待编辑决定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c608401801, createdName=ms9000001855664941, createdTime=Thu Dec 08 09:13:23 CST 2022, time=2022-12-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107436, encodeId=54fc210e436de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱 经验分享：还是比较快的，一审一个多月，大修后录取。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1JjG1vmt4PeQVwQy58nN7DUCHbhb9jnhSvcADOvbjdeIFVYrO8VeayjPYicG5DbRPtPTL1tiaVVicTLVUjXrF1WWg/132, createdBy=85db2404738, createdName=kk576, createdTime=Sun Dec 25 21:00:21 CST 2022, time=2022-12-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=925960, encodeId=ab1592596093, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审了将近四个月终于大修，凌晨提交傍晚就接收了，第一篇sci，很开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fc35388626, createdName=时坂紫, createdTime=Sun Feb 21 00:35:37 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588739, encodeId=20a8588e39de, content=我一篇临床文章被拒，被主编建议转投旗下杂志，被我拒绝，我改投一篇3分多的，结果接受了！dcn6460 2020-04-12 00:00:00 发表: 杂志由于目前收稿量大，对文章质量把关开始严格了。对于有兴趣但是达不到发表要求的文章会建议转投旗下的杂志。, beContent=dcn6460 2020-04-12 00:00:00 发表: 杂志由于目前收稿量大，对文章质量把关开始严格了。对于有兴趣但是达不到发表要求的文章会建议转投旗下的杂志。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203716, encodeId=4edb1203e162e, content=哪位同仁能分享一下投稿要求吗，guide for authors怎么也打不开了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325566391, createdName=ms3000000811234712, createdTime=Fri Mar 18 10:02:22 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966132, encodeId=c2eb966132ed, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：颅底肿瘤 经验分享：投稿很顺利，不到一个月接收。不过选择非OA会没有纸版文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42d93161, createdName=sunyanyien, createdTime=Sun May 16 23:46:33 CST 2021, time=2021-05-16, status=1, ipAttribution=)]

2021-05-16 sunyanyien

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：颅底肿瘤
经验分享：投稿很顺利，不到一个月接收。不过选择非OA会没有纸版文章吗？

75 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务